Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank50
3Y CAGR-9.7%
5Y CAGR-5.1%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-9.7%/yr
vs +20.5%/yr prior
5Y CAGR
-5.1%/yr
Recent deceleration
Acceleration
-30.1pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $43.80M | -20.7% |
| 2024 | $55.20M | -24.4% |
| 2023 | $73.00M | +22.9% |
| 2022 | $59.40M | +3.7% |
| 2021 | $57.30M | +0.7% |
| 2020 | $56.90M | +88.4% |
| 2019 | $30.20M | +7.1% |
| 2018 | $28.20M | +12.3% |
| 2017 | $25.12M | +249.1% |
| 2016 | $7.20M | - |